Renaissance Technologies’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Sell |
922,534
-511,300
| -36% | -$1.91M | ﹤0.01% | 1758 |
|
|
2025
Q1 | $3.96M | Buy |
1,433,834
+810,700
| +130% | +$2.24M | 0.01% | 1562 |
|
|
2024
Q4 | $3.45M | Buy |
623,134
+143,634
| +30% | +$796K | 0.01% | 1679 |
|
|
2024
Q3 | $4M | Buy |
479,500
+392,000
| +448% | +$3.27M | 0.01% | 1584 |
|
|
2024
Q2 | $596K | Buy |
+87,500
| New | +$596K | ﹤0.01% | 2613 |
|
|
2023
Q4 | – | Sell |
-290,100
| Closed | -$1.46M | – | 4128 |
|
|
2023
Q3 | $1.46M | Buy |
290,100
+236,900
| +445% | +$1.19M | ﹤0.01% | 2054 |
|
|
2023
Q2 | $466K | Sell |
53,200
-52,000
| -49% | -$455K | ﹤0.01% | 2909 |
|
|
2023
Q1 | $1.25M | Sell |
105,200
-9,700
| -8% | -$115K | ﹤0.01% | 2330 |
|
|
2022
Q4 | $1.17M | Sell |
114,900
-37,300
| -25% | -$380K | ﹤0.01% | 2437 |
|
|
2022
Q3 | $896K | Sell |
152,200
-32,216
| -17% | -$190K | ﹤0.01% | 2564 |
|
|
2022
Q2 | $457K | Buy |
184,416
+116,616
| +172% | +$289K | ﹤0.01% | 3210 |
|
|
2022
Q1 | $201K | Buy |
+67,800
| New | +$201K | ﹤0.01% | 3646 |
|